Clinical trials
Phase 2 Scleroderma, Diffuse trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 4 |
| United Therapeutics | 2 |
| Bristol-Myers Squibb | 1 |
| CSL Behring | 1 |
| Dinesh Khanna, MD, MS | 1 |
| Genentech, Inc. | 1 |
| Pfizer | 1 |
| Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Tanabe Pharma America, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Diffuse | 13 |
| Scleroderma, Systemic | 7 |
| Skin Diseases | 3 |
| Connective Tissue Diseases | 2 |
| Lung Diseases, Interstitial | 2 |
| Peripheral Vascular Diseases | 1 |
| Raynaud Disease | 1 |
| Scleroderma, Limited | 1 |
| Ulcer | 1 |
| Vascular Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.